MetaADEDB 2.0 @ LMMD
Guaifenesin
(HSRJKNPTNIJEKV-UHFFFAOYSA-N)
Structure
SMILES
OCC(COc1ccccc1OC)O
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
R05CA03
Molecular Formula:
C10H14O4
Molecular Weight:
198.216
Log P:
0.4272
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
58.92
CAS Number(s):
93-14-1
Synonym(s)
1.
Guaifenesin
2.
Guaiacol Glyceryl Ether
3.
Guaiphenesin
4.
Breonesin
5.
Glycerol Guaiacolate
6.
Guaiphenezine
7.
Guiatuss
8.
Humibid
9.
Hytuss
10.
My-301
11.
Scott-Tussin
12.
Ether, Guaiacol Glyceryl
13.
Glyceryl Ether, Guaiacol
14.
Guaiacolate, Glycerol
15.
My 301
16.
My301
17.
Scott Tussin
18.
ScottTussin
External Link(s)
MeSHD006140
PubChem Compound3516
ChEBI5551
CHEMBLCHEMBL980
DrugBankDB00874
DrugCentral1336
IUPHAR/BPS Guide to PHARMACOLOGY7617
KEGGdr:D00337
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 862
Canada Vigilance: 15
Canada Vigilance
US FAERS
2Incorrect drug administration durationFAERS: 343US FAERS
3No adverse eventFAERS: 319US FAERS
4Product use issueFAERS: 237US FAERS
5DizzinessFAERS: 181
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6HeadacheFAERS: 141SIDER
US FAERS
7NauseaFAERS: 128
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
8Feeling abnormalFAERS: 97US FAERS
9Drug abuseFAERS: 93
Canada Vigilance: 1
Canada Vigilance
US FAERS
10EpistaxisFAERS: 87US FAERS
11SomnolenceFAERS: 71US FAERS
12VomitingFAERS: 70
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
13Expired product administeredFAERS: 64US FAERS
14OverdoseFAERS: 55US FAERS
15UrticariaFAERS: 4711792017CTD
SIDER
US FAERS
16MalaiseFAERS: 45US FAERS
17Product use in unapproved indicationFAERS: 45US FAERS
18Inappropriate schedule of drug administrationFAERS: 43US FAERS
19FatigueFAERS: 40US FAERS
20Accidental overdoseFAERS: 38US FAERS
21HypersensitivityFAERS: 37US FAERS
22Abdominal discomfortFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
23PalpitationsFAERS: 36US FAERS
24Unevaluable eventFAERS: 35US FAERS
25PruritusFAERS: 31US FAERS
26AnxietyFAERS: 30US FAERS
27Wrong technique in product usage processFAERS: 30US FAERS
28Circumstance or information capable of leading to medication errorFAERS: 27US FAERS
29Accidental exposure to product by childFAERS: 26US FAERS
30NervousnessFAERS: 26US FAERS
31TremorFAERS: 24US FAERS
32ConstipationFAERS: 23US FAERS
33Therapeutic response unexpectedFAERS: 23US FAERS
34AstheniaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Chest PainFAERS: 21US FAERS
36LethargyFAERS: 21US FAERS
37ChokingFAERS: 19US FAERS
38Lip swellingFAERS: 19US FAERS
39ErythemaFAERS: 18US FAERS
40Feeling jitteryFAERS: 18US FAERS
41Burning sensationFAERS: 17US FAERS
42Medication residue presentFAERS: 17US FAERS
43Chest discomfortFAERS: 16US FAERS
44DysgeusiaFAERS: 16US FAERS
45Drug ineffective for unapproved indicationFAERS: 15US FAERS
46PneumoniaFAERS: 15US FAERS
47Blood glucose increasedFAERS: 14US FAERS
48DysuriaFAERS: 14US FAERS
49PainFAERS: 14US FAERS
50Product size issueFAERS: 14US FAERS
51DisorientationFAERS: 13US FAERS
52DyspepsiaFAERS: 13US FAERS
53Throat irritationFAERS: 13US FAERS
54Drug DependenceFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Oropharyngeal painFAERS: 12US FAERS
56Product quality issueFAERS: 12US FAERS
57Product taste abnormalFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
58AgitationFAERS: 11US FAERS
59Apparent deathFAERS: 11US FAERS
60DehydrationFAERS: 11US FAERS
61Euphoric moodFAERS: 11US FAERS
62Memory impairmentFAERS: 11US FAERS
63Peripheral swellingFAERS: 11US FAERS
64Abdominal PainFAERS: 10US FAERS
65Drug effect incompleteFAERS: 10US FAERS
66RetchingFAERS: 10US FAERS
67BronchitisFAERS: 9US FAERS
68Drug administered to patient of inappropriate ageFAERS: 9US FAERS
69HypotensionFAERS: 9US FAERS
70Incorrect dose administeredFAERS: 9US FAERS
71MydriasisFAERS: 9US FAERS
72SwellingFAERS: 9US FAERS
73Visual ImpairmentFAERS: 9US FAERS
74Blood urine presentFAERS: 8US FAERS
75ChromaturiaFAERS: 8US FAERS
76Medication ErrorFAERS: 8US FAERS
77DysarthriaFAERS: 7US FAERS
78FlushingFAERS: 7US FAERS
79Foreign body in respiratory tractFAERS: 7US FAERS
80Poor quality sleepFAERS: 7US FAERS
81Product solubility abnormalFAERS: 7US FAERS
82RestlessnessFAERS: 7US FAERS
83SyncopeFAERS: 7US FAERS
84ChillsFAERS: 6US FAERS
85DysphoniaFAERS: 6US FAERS
86Secretion dischargeFAERS: 6US FAERS
87Weight decreasedFAERS: 6US FAERS
88Wrong technique in drug usage processFAERS: 6US FAERS
89AgeusiaFAERS: 5US FAERS
90AmnesiaFAERS: 5US FAERS
91AnosmiaFAERS: 5US FAERS
92DiscomfortFAERS: 5SIDER
US FAERS
93Expired drug administeredFAERS: 5US FAERS
94Eye painFAERS: 5US FAERS
95FlatulenceFAERS: 5US FAERS
96MyalgiaFAERS: 5US FAERS
97Myocardial InfarctionFAERS: 5US FAERS
98Pharmaceutical product complaintFAERS: 5US FAERS
99Productive CoughFAERS: 5US FAERS
100Respiratory tract congestionFAERS: 5US FAERS
101Serotonin SyndromeFAERS: 5US FAERS
102SinusitisFAERS: 52309957
8607519
CTD
US FAERS
103Urinary IncontinenceFAERS: 5US FAERS
104VertigoFAERS: 5US FAERS
105AcneFAERS: 4US FAERS
106Adverse eventFAERS: 4US FAERS
107Anaphylactic shockFAERS: 4US FAERS
108GlaucomaFAERS: 4US FAERS
109IncoherentFAERS: 4US FAERS
110Joint swellingFAERS: 4US FAERS
111Musculoskeletal PainFAERS: 4US FAERS
112NasopharyngitisFAERS: 4US FAERS
113Product difficult to swallowFAERS: 4US FAERS
114Product physical issueFAERS: 4US FAERS
115Rash erythematousFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
116AlopeciaFAERS: 3US FAERS
117AngerFAERS: 3US FAERS
118AngioedemaFAERS: 3US FAERS
119AsthmaFAERS: 316197601CTD
US FAERS
120Cerebrovascular accidentFAERS: 3US FAERS
121DroolingFAERS: 3US FAERS
122Dry skinFAERS: 3US FAERS
123Eye irritationFAERS: 3US FAERS
124Feeling ColdFAERS: 3US FAERS
125Increased upper airway secretionFAERS: 3US FAERS
126InfectionFAERS: 3US FAERS
127Initial insomniaFAERS: 3US FAERS
128Intentional drug misuseFAERS: 3US FAERS
129Intentional product use issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
130NephrolithiasisFAERS: 3SIDER
US FAERS
131Oral painFAERS: 3US FAERS
132Product tamperingFAERS: 3US FAERS
133ScabFAERS: 3US FAERS
134ScreamingFAERS: 3US FAERS
135SneezingFAERS: 3US FAERS
136StaringFAERS: 3US FAERS
137Therapeutic product ineffectiveFAERS: 3US FAERS
138ThrombosisFAERS: 3US FAERS
139TinnitusFAERS: 3US FAERS
140Urinary RetentionFAERS: 3US FAERS
141Urinary tract infectionFAERS: 3US FAERS
142WheezingFAERS: 3US FAERS
143Accidental drug intake by childFAERS: 2US FAERS
144Accidental exposure to productFAERS: 2US FAERS
145Acute kidney injuryFAERS: 2US FAERS
146ArthralgiaFAERS: 2US FAERS
147ArthropathyFAERS: 2US FAERS
148Atrial FibrillationFAERS: 2US FAERS
149Atypical pneumoniaFAERS: 2US FAERS
150Back PainFAERS: 2US FAERS
151Back disorderFAERS: 2US FAERS
152Bladder painFAERS: 2US FAERS
153BronchospasmFAERS: 2US FAERS
154Cardiac ArrestFAERS: 2US FAERS
155CryingFAERS: 2US FAERS
156Deficiency of bile secretionFAERS: 2US FAERS
157DeliriumFAERS: 2US FAERS
158DependenceFAERS: 2US FAERS
159Depressed moodFAERS: 2US FAERS
160Diabetes MellitusFAERS: 2US FAERS
161Diastolic dysfunctionFAERS: 2US FAERS
162DissociationFAERS: 2US FAERS
163Drug dose omissionFAERS: 2US FAERS
164Drug screen negativeFAERS: 2US FAERS
165Drug screen positiveFAERS: 2US FAERS
166Drug withdrawal syndromeFAERS: 2US FAERS
167Ear discomfortFAERS: 2US FAERS
168Extra dose administeredFAERS: 2US FAERS
169Flank PainFAERS: 2US FAERS
170Gastrointestinal PainFAERS: 2US FAERS
171HungerFAERS: 2US FAERS
172HydronephrosisFAERS: 2US FAERS
173HyperchlorhydriaFAERS: 2US FAERS
174HypersomniaFAERS: 2US FAERS
175Increased viscosity of upper respiratory secretionFAERS: 2US FAERS
176Intentional self-injuryFAERS: 2US FAERS
177Intraocular pressure test abnormalFAERS: 2US FAERS
178LymphadenopathyFAERS: 2US FAERS
179MoaningFAERS: 2US FAERS
180Muscle tightnessFAERS: 2US FAERS
181Musculoskeletal chest painFAERS: 2US FAERS
182Nasal discomfortFAERS: 2US FAERS
183OliguriaFAERS: 2US FAERS
184OnychoclasisFAERS: 2US FAERS
185Opiates positiveFAERS: 2US FAERS
186Paranasal sinus hyposecretionFAERS: 2US FAERS
187ParanoiaFAERS: 2US FAERS
188Product dosage form issueFAERS: 2US FAERS
189Product expiration date issueFAERS: 2US FAERS
190Product packaging issueFAERS: 2US FAERS
191Product packaging quantity issueFAERS: 2US FAERS
192Product use complaintFAERS: 2US FAERS
193Renal painFAERS: 2US FAERS
194Restless Legs SyndromeFAERS: 2US FAERS
195Similar reaction on previous exposure to drugFAERS: 2US FAERS
196Skin irritationFAERS: 2US FAERS
197Sleep TalkingFAERS: 2US FAERS
198Sputum decreasedFAERS: 2US FAERS
199StomatitisFAERS: 2US FAERS
200Toxicity to various agentsFAERS: 2US FAERS
201Wrong drug administeredFAERS: 2US FAERS
202AbasiaFAERS: 1US FAERS
203Angina PectorisFAERS: 1US FAERS
204Angle Closure GlaucomaFAERS: 1US FAERS
205AphasiaFAERS: 1US FAERS
206AphoniaFAERS: 1US FAERS
207AsphyxiaFAERS: 1US FAERS
208Auricular swellingFAERS: 1US FAERS
209AutoscopyFAERS: 1US FAERS
210Blood pressure fluctuationFAERS: 1US FAERS
211Blood viscosity decreasedFAERS: 1US FAERS
212Bone painFAERS: 1US FAERS
213Bowel movement irregularityFAERS: 1US FAERS
214Bronchial secretion retentionFAERS: 1US FAERS
215CalcinosisFAERS: 1US FAERS
216Chemical injuryFAERS: 1US FAERS
217Choking sensationFAERS: 1US FAERS
218ClumsinessFAERS: 1US FAERS
219Completed SuicideFAERS: 1US FAERS
220Contraindicated drug administeredFAERS: 1US FAERS
221Contraindicated product administeredFAERS: 1US FAERS
222DeafnessFAERS: 1US FAERS
223DementiaFAERS: 1US FAERS
224Depressed Level of ConsciousnessFAERS: 1US FAERS
225DiplopiaFAERS: 1US FAERS
226Drug ToleranceFAERS: 1US FAERS
227Drug abuserFAERS: 1US FAERS
228Drug administration errorFAERS: 1US FAERS
229Drug dispensing errorFAERS: 1US FAERS
230Drug prescribing errorFAERS: 1US FAERS
231Drug screen false positiveFAERS: 1US FAERS
232Drug toxicityFAERS: 1US FAERS
233DystoniaFAERS: 1US FAERS
234Eating disorder symptomFAERS: 1US FAERS
235Electrocardiogram abnormalFAERS: 1US FAERS
236Electrolyte imbalanceFAERS: 1US FAERS
237Erectile dysfunctionFAERS: 1US FAERS
238Erection increasedFAERS: 1US FAERS
239EructationFAERS: 1US FAERS
240Erythema InfectiosumFAERS: 1US FAERS
241Erythema MultiformeFAERS: 1US FAERS
242Exposure during breast feedingFAERS: 1US FAERS
243Eyelid margin crustingFAERS: 1US FAERS
244Facial PainFAERS: 1US FAERS
245Flight of ideasFAERS: 1US FAERS
246Foreign body traumaFAERS: 1US FAERS
247Gait inabilityFAERS: 1US FAERS
248GastritisFAERS: 1US FAERS
249Genital infection fungalFAERS: 1US FAERS
250GlossitisFAERS: 1US FAERS
251Head discomfortFAERS: 1US FAERS
252HypoxiaFAERS: 1US FAERS
253Impaired work abilityFAERS: 1US FAERS
254Inappropriate schedule of product administrationFAERS: 1US FAERS
255IncontinenceFAERS: 1US FAERS
256Incorrect product administration durationFAERS: 1US FAERS
257Incorrect route of drug administrationFAERS: 1US FAERS
258Increased tendency to bruiseFAERS: 1US FAERS
259InfluenzaFAERS: 1US FAERS
260Intentional product misuseFAERS: 1US FAERS
261Intercepted drug dispensing errorFAERS: 1US FAERS
262Joint injuryFAERS: 1US FAERS
263LabyrinthitisFAERS: 1US FAERS
264Limb massFAERS: 1US FAERS
265Lung AbscessFAERS: 1US FAERS
266Mallory-Weiss SyndromeFAERS: 1US FAERS
267Mastication disorderFAERS: 1US FAERS
268Maternal exposure during pregnancyFAERS: 1US FAERS
269Medication residueFAERS: 1US FAERS
270Mental impairmentFAERS: 1US FAERS
271Middle insomniaFAERS: 1US FAERS
272Musculoskeletal stiffnessFAERS: 1US FAERS
273Neck PainFAERS: 1US FAERS
274Night sweatsFAERS: 1US FAERS
275Nonspecific reactionFAERS: 1US FAERS
276Obsessive-Compulsive DisorderFAERS: 1US FAERS
277Oropharyngeal blisteringFAERS: 1US FAERS
278Pain of skinFAERS: 1US FAERS
279PancreatitisFAERS: 1US FAERS
280ParasomniaFAERS: 1US FAERS
281Perinephric collectionFAERS: 1US FAERS
282Perinephric effusionFAERS: 1US FAERS
283Peripheral arterial occlusive diseaseFAERS: 1US FAERS
284PharyngitisFAERS: 1US FAERS
285Poor quality drug administeredFAERS: 1US FAERS
286Post-Traumatic Stress DisorderFAERS: 1US FAERS
287PresyncopeFAERS: 1US FAERS
288Product contaminationFAERS: 1US FAERS
289Product dispensing errorFAERS: 1US FAERS
290Product formulation issueFAERS: 1US FAERS
291Product label issueFAERS: 1US FAERS
292Product lot number issueFAERS: 1US FAERS
293Product outer packaging issueFAERS: 1US FAERS
294Product package associated injuryFAERS: 1US FAERS
295Product packaging difficult to openFAERS: 1US FAERS
296Pulmonary thrombosisFAERS: 1US FAERS
297Reaction to drug excipientsFAERS: 1US FAERS
298Rebound effectFAERS: 1US FAERS
299Respiratory FailureFAERS: 1US FAERS
300RhabdomyolysisFAERS: 1US FAERS
301SluggishnessFAERS: 1US FAERS
302SomnambulismFAERS: 1US FAERS
303Sudden deathFAERS: 1US FAERS
304TachycardiaFAERS: 1US FAERS
305Therapeutic product contaminationFAERS: 1US FAERS
306Thermal burnFAERS: 1US FAERS
307ThirstFAERS: 1US FAERS
308ThrombocytopeniaFAERS: 1US FAERS
309Tongue discomfortFAERS: 1US FAERS
310ToothacheFAERS: 1US FAERS
311Transcription medication errorFAERS: 1US FAERS
312Upper-airway cough syndromeFAERS: 1US FAERS
313Urine flow decreasedFAERS: 1US FAERS
314Vaginal DischargeFAERS: 1US FAERS
315Vitreous floatersFAERS: 1US FAERS
316Vulvovaginal rashFAERS: 1US FAERS
317DermatitisSIDER
318Drug Eruptions11792017CTD
319Gluten sensitivityCanada Vigilance: 1Canada Vigilance
320Kidney Calculi10608519
15673990
CTD
321Poor quality product administeredCanada Vigilance: 1Canada Vigilance
322Product physical consistency issueCanada Vigilance: 1Canada Vigilance
323Stoma site painCanada Vigilance: 1Canada Vigilance
324Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
325Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
326Ureteral Calculi14751382CTD
327Urinary Calculi10414721
15759201
16197601
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.